ClinicalTrials.gov
public full text
Public Domain
Lutein and Alzheimer's Disease Study
Oxidative damage by free radicals may be involved in causing Alzheimer's disease (AD). Free radicals may lead to death of nerve cells and decline in brain function. Certain antioxidants may suppress this free radical damage associated with AD. Carotenoids are a family of naturally occurring antioxidants that have important functions for human health. Carotenoids are known to reduce oxidative damage, but their effects have not been studied in AD patients. The objective of the study is to examine whether lutein supplementation helps to reduce oxidative damage from free radicals in AD patients.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- The contribution of oxidative stress in the protein damage and DNA lesion in Alzheimer's disease neuropathology#957884
- Nutraceuticals: Food-based therapeutics and health benefits#93911
- Use of a free radical method to evaluate antioxidant activity#6931
- Fish Oil and Alpha Lipoic Acid in Treating Alzheimer's Disease#853198
- Identification and Validation of the Nrf2/Slc2a1 Axis in Alzheimer's Disease#1133212
Record · ID 981044
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive